Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00801060
Recruitment Status : Terminated
First Posted : December 3, 2008
Last Update Posted : October 2, 2015
Sponsor:
Information provided by (Responsible Party):
Biogen

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 2010
Actual Study Completion Date : September 2010
Certification/Extension First Submitted : September 17, 2015